Abstract:Background There is a need to better understand the role of modifiable risk factors in the development of racial/ethnic health disparities in Alzheimer's disease (AD). In particular, research is lacking on how clinical risk scores may interact with genetic liability for dementia in diverse populations. Here, we examined the influence of the Cardiovascular Risk Factors, Aging, and Incidence of Dementia Risk Score (CAIDE) and APOE genotype on MCI/Dementia risk in non‐Latinx White (NLW), Black, and Latinx populations. Method Participants were from the National Alzheimer's Coordinating Center Uniform Dataset who self‐reported as NLW (n = 15,296), Black (n = 2,136), or Latinx (n = 955) who were either cognitively normal or had a clinical diagnosis of MCI/Dementia at baseline (Table 1). CAIDE is comprised of age, gender, years of education, hypertension, obesity, and hypercholesteremia with scores ranging from 0‐14. Logistic regression models stratified by race/ethnicity were used to examine the association between CAIDE, APOE genotype, or their combination (9 categories combining favorable, intermediate, and unfavorable CAIDE scores with APOE e3/e3, e2+, and e4+) on MCI/dementia (Fig. 1‐2). Population differences were determined using Fisher's z‐score method. Results APOE e2+ was associated with reduced odds of MCI/dementia in NLW participants, while APOE e4+ was associated with increased risk in Latinx, Black, and NLW participants. Higher CAIDE scores were associated with increased risk of MCI/dementia in Latinx and NLW but were non‐significant in Black participants. The association of CAIDE on MCI/dementia in Black participants was significantly different from that in NLW and Latinx participants. Similarly, the effect of APOE e4+ on the risk of MCI/dementia was weaker in Latinx compared to NLW participants. In NLW, increasingly unfavorable modifiable risk profiles attenuated the protective effect of APOE e2+ and accentuated the deleterious impact of APOE e4+ on MCI/dementia. In Black participants, modifiable risk factors did not significantly affect the relationship between APOE genotype and MCI/dementia; in Latinx participants, there was only a moderate effect. Conclusion The risk associated with APOE on MCI/Dementia is moderated by modifiable risk factors with suggestive population‐specific effects. Addressing health disparities will require risk scores that combine clinical, genetic, and social determinants of health and are applicable across diverse populations.

Utilizing apolipoprotein E genotypes and associated comorbidities for the assessment of the risk for dementia

Association Study of Apolipoprotein E Gene Polymorphisms with Geriatric Depression

Associations Between APOE Genotype and Cerebral Small-Vessel Disease: a Longitudinal Study

Interactions between the apolipoprotein E4 gene and modifiable risk factors for cognitive impairment: a nationally representative panel study

APOE epsilon variants and composite risk of dementia, disability, and death in the health and retirement study

Synergistic effect between apolipoprotein E ε4 and diabetes mellitus for dementia: result from a population-based study in urban China.

Associations Between APOE Polymorphisms and Seven Diseases with Cognitive Impairment Including Alzheimer’s Disease, Frontotemporal Dementia, and Dementia with Lewy Bodies in Southeast China

Comorbidity of Dementia: A Cross-Sectional Study of PUMCH Dementia Cohort

The Application Value of ApoE Gene Polymorphism in Alzheimer's Disease

IC-P-060: Decreased Intrinsic Functional Network in Cognitively Intact Elderly APOE-E4 Carriers Measured by Eigenvector Centrality Mapping

Effects of Apolipoprotein E on Dementia and Aging in the Shanghai Survey of Dementia

Correlation Between the APOE Ε4 Genotype, Lifestyle Habits, and Cognitive Deficits in Chinese Adults over 60: a Cross-Sectional Analysis in China

Association of APOE ε4/ε4 with fluid biomarkers in patients from the PUMCH dementia cohort

Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia

Relationships between APOE, Type 2 Diabetes, and Cardiovascular Disease in Postmenopausal Women

Apolipoprotein E Induced Cognitive Dysfunction: Mediation Analysis of Lipids and Glucose Biomarkers in an Elderly Cohort Study

Examining the Interactive Effect of Cardiovascular Risk Factors and APOE Genotype on Population Health Disparities in dementia risk

Associations between apolipoprotein E gene polymorphisms and Alzheimer's disease risk in a large Chinese Han population.

Effects of ApoE genotype on clinical phenotypes in early‐onset and late‐onset Alzheimer's disease in China: Data from the PUMCH dementia cohort

Correlation between cognitive function and ApoE genotypes in the elderly with four different cognitive states

Associations Between Apolipoprotein E Gene Polymorphisms and Alzheimer&rsquo;s Disease Risk in a Large Chinese Han Population